[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Co-Diagnostics Inc (CODX)

Co-Diagnostics Inc (CODX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,227
  • Shares Outstanding, K 3,685
  • Annual Sales, $ 620 K
  • Annual Income, $ -46,900 K
  • EBIT $ -31 M
  • EBITDA $ -30 M
  • 60-Month Beta 2.74
  • Price/Sales 30.58
  • Price/Cash Flow N/A
  • Price/Book 1.16

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-6.91
  • Growth Rate Est. (year over year) +14,557.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.26 +346.83%
on 05/15/26
13.54 -58.42%
on 05/28/26
+4.04 (+254.09%)
since 05/05/26
3-Month
1.26 +346.83%
on 05/15/26
13.54 -58.42%
on 05/28/26
+3.30 (+141.63%)
since 03/05/26
52-Week
1.26 +346.83%
on 05/15/26
46.50 -87.89%
on 10/27/25
-3.50 (-38.31%)
since 06/05/25

Most Recent Stories

More News
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dxâ„¢ PCR Point-of-Care Platform Capabilities

Dual-assay strategy designed to support outbreak response and surveillance efforts in affected regions

CODX : 5.63 (-2.26%)
Is Co-Diagnostics National Security’s Next Diagnostic Pick?

Global health emergencies are shifting sovereign biodefense strategies toward decentralized diagnostic networks capable of deploying rapid stockpiles.

OSUR : 4.04 (-3.12%)
GOVX : 1.6500 (-7.82%)
CODX : 5.63 (-2.26%)
Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

Joint development strategy has been developed to address international deployment requirements if current outbreak continues or expands globally

CODX : 5.63 (-2.26%)
Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

Recent pathogens illustrate need for improved situational awareness capabilities, such as those provided by the Co-Dx PCR point-of-care platform

CODX : 5.63 (-2.26%)
Co-Diagnostics Reports First Quarter 2026 Financial Results

Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion

CODX : 5.63 (-2.26%)
Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City

Lease execution highlights transition from approval to development and advances localized manufacturing strategy in the Kingdom of Saudi Arabia in accordance with Vision 2030

CODX : 5.63 (-2.26%)
Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast

SALT LAKE CITY , April 30, 2026 /PRNewswire/ -- Co-Diagnostics, Inc.  (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...

CODX : 5.63 (-2.26%)
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City

Facility in Sudair Industrial City is expected to position CoMira among the early domestic manufacturers of molecular diagnostic testing solutions in Saudi Arabia

CODX : 5.63 (-2.26%)
Co-Diagnostics Reports Full Year 2025 Financial Results

Advancing Global Commercialization Strategy Through CoSara and CoMira Joint Ventures

CODX : 5.63 (-2.26%)
Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

The near-term commencement of clinical studies is expected to align with recent WHO tuberculosis recommendations for near-point-of-care molecular testing and utilizing tongue swab samples

CODX : 5.63 (-2.26%)

Business Summary

Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology...

See More

Key Turning Points

3rd Resistance Point 7.20
2nd Resistance Point 6.64
1st Resistance Point 6.13
Last Price 5.63
1st Support Level 5.06
2nd Support Level 4.50
3rd Support Level 3.99

See More

52-Week High 46.50
Fibonacci 61.8% 29.22
Fibonacci 50% 23.88
Fibonacci 38.2% 18.54
Last Price 5.63
52-Week Low 1.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.